Medicinal Products

Amgevita

Name Amgevita
Active Substance adalimumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L04AB04
Medicinal product marketed in the Croatia Da
Educational materials
for patients / caregivers
Kartica sa informacijama za bolesnike

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/amgevita

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Back